HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elsa Arribas Selected Research

Residual Neoplasm

1/2018A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elsa Arribas Research Topics

Disease

2Triple Negative Breast Neoplasms
01/2021 - 01/2021
2Neoplasms (Cancer)
01/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
07/2018 - 01/2018
2Calcinosis
06/2008 - 01/2005
1Necrosis
01/2021
1Pathologic Complete Response
07/2018
1Residual Neoplasm
01/2018
1Hyperplasia
02/2015
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2014

Drug/Important Bio-Agent (IBA)

2Calcium Carbonate (Limestone)FDA Link
06/2008 - 01/2005
1Cadherins (E-Cadherin)IBA
02/2015

Therapy/Procedure

4Neoadjuvant Therapy
01/2021 - 01/2018
1Breast Implants (Breast Implant)
08/2014